Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Submitted by
admin
on February 28, 2017 - 11:12am
Source:
Yahoo/Reuters
News Tags:
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Headline:
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Do Not Allow Advertisers to Use My Personal information
